Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China [PDF]
Pathogens, 2021 Haemophilus parasuis can cause high morbidity and mortality in swine. Cefquinome possesses excellent antibacterial activity against pathogens causing diseases of the respiratory tract.
Kun Mi +7 more
doaj +5 more sources
Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF [PDF]
Antibiotics, 2021 Background: In order to establish the clinical breakpoint (CBP) of danofloxacin against G. parasuis, three cutoff values, including epidemiological cutoff value (ECV), pharmacokinetic-pharmacodynamic (PK-PD) cutoff value (COPD) and clinical cutoff value (
Zihui Xu +11 more
doaj +6 more sources
Optimal Regimens and Clinical Breakpoint of Avilamycin Against Clostridium perfringens in Swine Based on PK-PD Study [PDF]
Frontiers in Pharmacology, 2022 Clostridium perfringens causes significant morbidity and mortality in swine worldwide. Avilamycin showed no cross resistance and good activity for treatment of C. perfringens.
Anxiong Huang +21 more
doaj +2 more sources
Prudent Use of Tylosin for Treatment of Mycoplasma gallisepticum Based on Its Clinical Breakpoint and Lung Microbiota Shift [PDF]
Frontiers in Microbiology, 2021 The aim of this study was to explore the prudent use of tylosin for the treatment of chronic respiratory infectious diseases in chickens caused by Mycoplasma gallisepticum (MG) based on its clinical breakpoint (CBP) and its effect on lung microbiota. The
Anxiong Huang +19 more
doaj +2 more sources
Rational Use of Danofloxacin for Treatment of Mycoplasma gallisepticum in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift [PDF]
Antibiotics, 2022 The study was to explore the rational use of danofloxacin against Mycoplasma gallisepticum (MG) based on its clinical breakpoint (CBP) and the effect on lung microbiota.
Shuge Wang +10 more
doaj +2 more sources
A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints [PDF]
Journal of Fungi, 2022 EUCAST has established clinical breakpoints for the six most common Candida species and Cryptococcus neoformans but not for less common yeasts because sufficient evidence is lacking. Consequently, the question “How to interpret the MIC?” for other yeasts
Karen Marie Thyssen Astvad +2 more
doaj +5 more sources
Assessment of long-read strategies for the enrichment of clinically relevant breakpoints in lymphomas: towards a diagnostic implementation [PDF]
Annals of HematologyRecurrent chromosomal translocations are hallmarks of many hematological malignancies, including lymphomas and leukemias. Accurate breakpoint detection is essential for diagnostics, treatment optimization, and disease monitoring.
Filip Pardy +6 more
doaj +2 more sources
International Journal of Mycobacteriology, 2022 Background: Recently, moxifloxacin (MFX)-resistant results of Mycobacterium tuberculosis (Mtb) obtained by GenoType MTBDRsl (second-line line probe assay [SL-LPA]) have been stratified to determine their resistance level; however, its accuracy has not ...
Raj Narayan Yadav +5 more
doaj +1 more source
Determination of Susceptibility Breakpoint for Cefquinome against Streptococcus suis in Pigs
Antibiotics, 2021 Streptococcus suis (S. suis), a zoonotic pathogen, causes severe diseases in both pigs and human beings. Cefquinome can display excellent antibacterial activity against gram-negative and gram-positive bacteria.
Kun Mi +9 more
doaj +1 more source